Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortization of GoodwillAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Health Catalyst (HCAT) Share-based Compensation (2018 - 2025)

Historic Share-based Compensation for Health Catalyst (HCAT) over the last 8 years, with Q3 2025 value amounting to $7.0 million.

  • Health Catalyst's Share-based Compensation fell 2599.87% to $7.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $33.7 million, marking a year-over-year decrease of 2034.16%. This contributed to the annual value of $40.1 million for FY2024, which is 2802.93% down from last year.
  • Per Health Catalyst's latest filing, its Share-based Compensation stood at $7.0 million for Q3 2025, which was down 2599.87% from $8.3 million recorded in Q2 2025.
  • In the past 5 years, Health Catalyst's Share-based Compensation ranged from a high of $18.7 million in Q4 2022 and a low of $7.0 million during Q3 2025
  • In the last 5 years, Health Catalyst's Share-based Compensation had a median value of $13.9 million in 2023 and averaged $13.5 million.
  • As far as peak fluctuations go, Health Catalyst's Share-based Compensation skyrocketed by 9596.51% in 2021, and later crashed by 3871.08% in 2024.
  • Quarter analysis of 5 years shows Health Catalyst's Share-based Compensation stood at $16.4 million in 2021, then increased by 14.17% to $18.7 million in 2022, then tumbled by 30.6% to $13.0 million in 2023, then fell by 16.9% to $10.8 million in 2024, then tumbled by 34.9% to $7.0 million in 2025.
  • Its Share-based Compensation stands at $7.0 million for Q3 2025, versus $8.3 million for Q2 2025 and $7.5 million for Q1 2025.